Lauren Young
About Lauren Young
Lauren Young, age 42, is a Class II independent director of CCC Intelligent Solutions Holdings Inc. (CCCS), serving since July 30, 2021 with a current term expiring at the fiscal year 2026 annual meeting. She is a Managing Director at Advent International and holds a bachelor’s degree from Davidson College and an MBA from Harvard Business School .
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| Advent International, L.P. | Managing Director (joined firm in 2011) | 2011–present | Private equity leadership and board oversight across technology/financial sectors |
| The Carlyle Group | U.S. Buyout Fund team member | 2006–2009 | Investment execution in large-cap buyouts |
| McColl Partners | Analyst | 2004–2006 | Sell-side and buy-side transaction analysis |
External Roles
| Organization | Role | Public/Private | Notes |
|---|---|---|---|
| Definitive Healthcare | Director | Public | Current board service |
| Iodine Software | Director | Private | Current board service |
Board Governance
- Board and committee activity in FY2024: Board met 8 times; Audit 7; Nominating & Corporate Governance (NCGC) 3; Human Capital & Compensation (HCCC) 5 .
- Attendance: In FY2024, each director other than Christopher Egan attended at least 75% of Board and committee meetings during their tenure (implies Ms. Young met or exceeded 75%) .
- Committee memberships: NCGC member (Chair: Eric Wei; members: Teri Williams, Lauren Young). All NCGC members are independent under Nasdaq/SEC rules .
- Not on Audit or HCCC per the committee rosters .
- Independence: Company states seven independent directors and confirms committee independence; Ms. Young is treated as independent under Nasdaq/SEC standards .
- Board leadership: CEO also Chair; a “presiding director” ensures independent leadership—currently Eric Wei (an Advent designee) .
Fixed Compensation
| Component | Amount | Terms |
|---|---|---|
| Annual cash retainer | $0 | Company pays $15,000 quarterly retainer to eligible non-employee directors; CCC does not compensate directors employed by CCC or by the Advent Investor/affiliates (Ms. Young receives no cash fees) . |
| Committee chair fee | $0 | $25,000 RSU chair grant applies to eligible chairs; not paid to Advent-affiliated directors . |
| Meeting fees | $0 | Not disclosed/none in policy; directors compensated via retainers/annual grants only . |
| Annual equity RSU grant | $0 | $250,000 RSU grant to eligible directors; not granted to Advent-affiliated directors (Ms. Young had no 2024 director stock awards) . |
Performance Compensation
| Metric | Design | Payout |
|---|---|---|
| N/A for Ms. Young | CCC director pay is retainers and time-vested RSUs (no performance metrics); Advent-affiliated directors (including Ms. Young) receive no cash or equity director compensation . |
Other Directorships & Interlocks
- Advent Investor designation rights: Shareholder Rights Agreement grants Advent the right to designate directors and to have at least one Advent-nominated director on each Board committee while Advent maintains specified ownership thresholds; Ms. Young is an Advent-designated director .
- CCC repurchased 7 million shares from Advent on March 3, 2025 at $10.325 per share ($72.3M); terms were reviewed and approved by CCC’s independent Audit Committee. This is a related-party transaction with a >5% holder processed through independent oversight .
Expertise & Qualifications
- Finance and investing expertise from Advent/Carlyle; board experience in technology and healthcare software (Definitive Healthcare, Iodine Software) .
- Academic credentials: Davidson College (BA), Harvard Business School (MBA) .
Equity Ownership
| Holder | Shares Beneficially Owned | % of Outstanding | Notes |
|---|---|---|---|
| Lauren Young | — | — | No personal beneficial ownership reported as of April 1, 2025 . |
| Advent Investor (affiliates) | 97,342,526 | 14.77% | Major shareholder; Ms. Young is an Advent MD and designee . |
Additional alignment policies:
- Director stock ownership guidelines: Non-employee directors should hold shares equal to 3x annual cash fees; measured within five years. (Ms. Young receives no cash fees; guideline framework disclosed but individual compliance not specified) .
- Anti-hedging/pledging: Hedging and pledging of CCC securities prohibited without pre-approval; applies to directors .
Governance Assessment
- Advent influence and independence: Ms. Young is independent under Nasdaq/SEC rules yet is an Advent-appointed director with no personal CCCS share ownership; alignment is primarily through Advent’s significant equity stake rather than personal holdings .
- Compensation and incentives: Ms. Young receives no CCC director cash or equity—reducing potential cash/equity conflicts but also limiting direct “skin-in-the-game” at the individual level (contrasted with CCC’s general director RSU program) .
- Committee composition and oversight: Ms. Young serves on NCGC alongside Advent designees; Advent has rights to committee representation, including at least one director on each committee while above thresholds—heightening shareholder influence considerations but within disclosed governance arrangements .
- Related-party safeguards: 2025 share repurchase from Advent was reviewed and approved by CCC’s independent Audit Committee, indicating process controls for transactions with the principal shareholder .
- Attendance and engagement: Board/committee cadence was robust in 2024; directors (including Ms. Young) met or exceeded the 75% attendance threshold .
- Shareholder sentiment: 2024 say-on-pay passed with ~68% support, suggesting moderate investor scrutiny of pay practices and governance (a broader signal for the Board) .
RED FLAGS and Watch Items:
- Advent control features: Board/committee designation rights and a presiding director from Advent concentrate influence; monitor for potential conflicts in nominations/succession and ESG oversight .
- Zero personal ownership: Ms. Young reports no direct CCCS holdings; while policy allows for Advent-affiliated directors to forgo compensation, individual ownership alignment is limited (offset by Advent’s 14.77% stake) .
- Related-party activity: Ongoing capital markets transactions with Advent (e.g., repurchases) require continued independent committee oversight to mitigate conflicts .